Physicians around the world have been able to take back control of their schedules, achieve low re-excision rates and give their patients a better experience with the Magseed® marker. Used in more countries around the world than any other seed technology the Magseed® marker has been subject to numerous regulatory approvals, clinical trials, new product evaluations and appeared in numerous peer-reviewed papers.
Here you can read these clinical assessments in full and see how Magseed® marker compares to alternative technologies.
A study to assess the safety and feasibility of the Magseed® marker, specifically migration.
The initial experience of an academic teaching institute in implementing a Magseed® marker lesion localisation program.
A retrospective review of 188 patients receiving Magseed® markers for lesion localisation.
The largest single institution experience of Magseed® marker for operative localization of non-palpable breast lesions to date (page 96)
A single centre study investigating the effectiveness of the Magseed® marker for lesion localisation
If you would like to read additional literature relating to the Magseed® marker and its safety, effectiveness and clinical results, please get in touch and we will be happy to assist you.